The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The GCC intravenous solutions market is currently witnessing moderate growth. Intravenous (IV) solutions refer to a mix of chemically prepared fluids that are administered in the body through venous circulation. They are composed of medications and nutrients such as carbohydrates, amino acids, salts, electrolytes, vitamins, and minerals. IV solutions provide nutrients to patients suffering from cancer, diabetes, immune deficiencies, heart failure and other related diseases. In the GCC region, the demand for intravenous therapy has escalated as it offers rapid onset of drug effects compared to other drug delivery systems.
The GCC intravenous solutions market is primarily driven by the growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes in the region. Apart from this, governments of several GCC countries, like Saudi Arabia, Oman and Qatar, are undertaking initiatives to offer better healthcare facilities to the people, which has increased the demand for IV solutions in the region. Besides this, the introduction of new intravenous solution products for different diseases and the treatment of dehydration is catalyzing the growth of the market. Furthermore, the faster response time and the rapid onset of drugs offered in the IV solution therapy are significant factors contributing to the market growth. Looking forward, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC intravenous solutions market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
Breakup by Nutrients:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at